Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-30
DOI
10.3389/fonc.2020.00441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- Plasma MicroRNA Pair Panels as Novel Biomarkers for Detection of Early Stage Breast Cancer
- (2019) Rui Fang et al. Frontiers in Physiology
- Prognostic models for breast cancer: a systematic review
- (2019) Minh Tung Phung et al. BMC CANCER
- Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma
- (2019) Xiang-Guang Wu et al. ANGIOGENESIS
- Emerging roles of exosomal miRNAs in breast cancer drug resistance
- (2019) Hamid Najminejad et al. IUBMB LIFE
- Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study)
- (2018) Atefe Abak et al. Clinical Laboratory
- microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
- (2018) Sinae Kim et al. ONCOGENE
- Effect of vinca alkaloids on the expression levels of microRNAs targeting apoptosis-related genes in breast cancer cell lines
- (2018) Adamantios V. Mavrogiannis et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer
- (2017) Kuan Ning et al. JOURNAL OF SURGICAL ONCOLOGY
- Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
- (2017) Lorenzo Sempere et al. Cancers
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer
- (2016) Yuan Tang et al. Clinical Breast Cancer
- PI3-kinase mutation linked to insulin and growth factor resistance in vivo
- (2016) Jonathon N. Winnay et al. JOURNAL OF CLINICAL INVESTIGATION
- Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer
- (2016) Xiaohong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma
- (2016) Jian-Kai Yang et al. JOURNAL OF NEURO-ONCOLOGY
- MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1
- (2016) Lijun Zhao et al. TUMOR BIOLOGY
- HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B
- (2016) Daniel C. Kirouac et al. PLoS Computational Biology
- Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study
- (2016) Ke Wang et al. PLoS One
- The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance
- (2015) Lei Zhao et al. CANCER LETTERS
- Exosomes in development, metastasis and drug resistance of breast cancer
- (2015) Dan-dan Yu et al. CANCER SCIENCE
- The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines
- (2015) Sercan Ergun et al. GENE
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
- (2015) LI-XU YAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities
- (2014) Ting-Yu Chang et al. BMC GENOMICS
- The Anti-Oxidative Role of Micro-Vesicles Derived from Human Wharton-Jelly Mesenchymal Stromal Cells through NOX2/gp91(phox) Suppression in Alleviating Renal Ischemia-Reperfusion Injury in Rats
- (2014) Guangyuan Zhang et al. PLoS One
- miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
- (2013) Kinya Okamoto et al. PLoS One
- miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
- (2011) M Acunzo et al. ONCOGENE
- Nuclear β-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells
- (2010) Masahiro Uchino et al. BMC CANCER
- Inhibition of PI3K/Akt partially leads to the inhibition of PrPC-induced drug resistance in gastric cancer cells
- (2008) Jie Liang et al. FEBS Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More